You are here

Brazil issues first license for sale of a cannabis-based drug

Brazilian healthcare regulator Anvisa on Monday said it had issued the country’s first license for sale of a cannabis-based drug in the country after years of legal wrangling with patients. The multiple sclerosistreatment, an oral spray derived from marijuana and developed by Britain’s GW Pharmaceuticals PLC, is known as Sativex internationally and will be sold in Brazil under the brand name Mevatyl. The legal status of cannabis-based drugs has been a thorny issue in Brazil for years, with several patients fighting in the courts to circumvent prohibition. Anvisa has loosened…

Read More

Jolla Secures extra investment to broaden and License Sailfish OS

Jolla, the Finnish cell company and developer of open mobile working machine Sailfish OS, introduced that it has secured $12 million (more or less Rs. 79 crores) in new financing to strengthen its OS licensing commercial enterprise, following its ultimate fund-increase in December 2015 . Powered with the aid of its new investments, the startup stated it’s going to continue to expand its Sailfish OS, proceed with final the Jolla tablet venture, and enlarge its licensing partnerships. Jolla is likewise making ready a brand new special community program, to be…

Read More